We prospectively studied, for 1 year initially, higher mortality (12-month mortality 14% in women vs. 6% in men), and higher morbidity in 353 consecutive patients (297 male 56 female, 57.2±7.32 years) with chronic stable angina admitterms of readmissions, angina symptoms, antianginal drug use and effort tolerance. This series ted for coronary artery bypass graft (CABG) surgery in the North East of England. Patients generally had describes clinical practice in an area of high coronary disease morbidity and mortality. It identifies the severe anginal symptoms (median 36 months duration) despite anti-anginal therapy (90% taking two real risks for women with severe symptomatic disease undergoing coronary artery surgery. We believe or more anti-anginal drugs). Women were more severely symptomatic than men prior to surgery, it highlights the need for improved risk stratification in the treatment of women with angina, and a despite a similar severity of angiographically-defined coronary artery disease, suggesting possible referral consideration of alternative treatment strategies for those women destined to have a poor outcome bias. Women were given fewer grafts than men in operations carrying similar risks. After surgery, clinfrom CABG. ical outcome was generally good but women had a
Introduction
Coronary bypass graft surgery (CABG) is one of the such subsets. Considerable interest has focussed on the treatment of women with coronary artery disease, most frequently practised operations in the Western both in the US4-7 and the UK,8,9 as few of the trial world. Its benefits, both in relieving angina, and in patients were women, and there were early suggesmany patients, in prolonging survival, are welltions that the outcome of women undergoing coronestablished in randomized clinical trials1,2 and in ary surgery was not as good as that of men. In meta-analyses.3 However, we must be cautious in addition, much of the data regarding gender differtranslating the results of such randomized clinical ences in response to surgery are derived from treattrials into clinical practice. For this reason we have ment within a very different health-care system from examined the result of surgery in a prospective that in the UK. For these reasons, we felt it important cohort from the North of England, where the standto examine the impact of gender on outcome from ardized mortality rate for coronary artery disease is coronary surgery in the UK. high, and severe disease will be perhaps more
In this report, we compare the clinical outcome prevalent than in many previous studies. There are of coronary surgery in a prospectively studied conalso important subgroups of patients who have been secutive, unselected series of 297 men and 56 studied in insufficient numbers in the trials to allow women, followed for one year after coronary bypass surgery in a single centre in the North of England. us confidence in the applicability of study results to 1989 , were prospectively studied. These patients were from a geographically-defined population of Coronary artery disease severity was classified using 3.2 million people. Patients had chronic stable the same criteria as for the coronary artery surgery angina or recently settled unstable angina. Fifteen study (CASS).1 A lesion reducing the internal diameter patients were excluded, eight from outside the of the left main coronary artery (LMS) by 50% or Northern Region, three because of concomitant valvmore was considered significant. A lesion was ular heart disease, one because surgery was deferred defined in the left anterior descending, circumflex, because of continued smoking, and three patients right coronary artery, or major epicardial branch of refused to participate. Thus, 353 patients (297 men them, if the internal diameter was reduced by 70% and 56 women) were prospectively followed for 1 or more and this constituted significant disease in year after surgery. Informed consent was obtained the territory subtended by that coronary artery. Left from all patients, and the protocol was approved by ventricular function was assessed in standard 30°t he Newcastle Joint Ethics Committee.
right anterior oblique and 60°left anterior oblique projections. Left ventricular function was defined as follows:1 normal (no wall-motion abnormality);
Clinical follow-up impaired (any regional wall-motion abnormality present); poor (major regional wall-motion abnormalities Eighty-five percent of possible patients were seen in and high left-ventricular end-diastolic pressure). We a study clinic at 3, 6, and 12 months after surgery.
obtained operation details, including the position of The remainder were visited at their home (<3%), graft insertion and type of conduit used, from surfilled in questionnaires by mail, or were interviewed gical records. by phone (5% 
Results

Other symptoms
Patient characteristics (pre-operative)
Self perceived effort tolerance was assessed using the question 'what is the furthest distance you walk The distribution of patient age and duration of anginal symptoms was the same in both sexes (in one stretch) each day'. Symptoms of heart failure (swelling of ankles, orthopnoea, paroxysmal noc- (Table 1 ). Women and men had a similar prevalence of previous myocardial infarcation, vascular disease turnal dyspnoea) and the most limiting symptom experienced (chest pain, breathlessness, lethargy, and identified risk factors, with the exception of treated hypertension which was twice as common other) was recorded. The presence of intermittent claudication was determined using the criteria of the in women as in men ( p<0.005; OR 2.8 (95% CI 2.1-3.8)). WHO Rose questionnaire. Before surgery, 98% of patients had angina, 71% (women 85% vs. men 70%, p<0.05; OR 2.0 (95% CI 0.9-4.6)). having grade 3 or 4 symptoms ( Figure 1 ). For the majority of patients (79% of women and 81% of Pre-operatively, women were also more likely to have a poor effort tolerance (less than 1/4 mile in men), angina, in some combined with shortness of breath, was the limiting symptom. A higher propor-66% of women vs. 35% of men, p<0.01; OR 3.6 (95% CI 0.9-13.0) (Figure 2 ). At least one symptom tion of women than men had grade 3 or 4 angina The left internal mammary artery was used for grafting in 266 (75%) of cases and the right internal mammary artery in 46 (13%) of cases. They were equally used in men and women. Only 21 patients (6%) received internal mammary artery grafts as the only graft. Women received fewer graft conduits than men with fewer distal anastomoses (Table 2) and particularly fewer grafts to the circumflex territory.
Outcomes Mortality
In-hospital mortality was the same in women as in men (2 (3.6%) women, 10 (3.4%) men, OR 1.06, was higher in women than in men (8 (14.3%) women, 19 (6.4%) men; OR 2.4, 95% CI 1.09-6.30, of congestive cardiac failure (swelling of ankles, p<0.001 (log rank)) ( Figure 4 ). There were 15 (56%) orthopnoea, paroxysmal nocturnal dyspnoea) was definite cardiac deaths, and two (7%) probable present pre-operatively in 71% of women and 35% cardiac deaths. Non-cardiac, surgery-related deaths of men ( p<0.001; OR 4.55 (95% CI 0.9-42.0)).
accounted for a further six (22%), and non-cardiac, Use of anti-anginal drugs was the same in women non-surgical deaths for four (15%) of the first year and men before surgery (Figure 3) , as was the propormortality. tion taking antiplatelet drugs (53% of women, 51% of men) and buccal and sublingual nitrates (92% of Readmissions women, 84% of men).
Readmissions were common, affecting 31% of the cohort by the end of the first post-operative year.
Coronary disease severity and operation
Only 50% of re-admissions were for cardiac indications or post-operative problems (Table 3) . During There was no significant difference between men and women in the pattern or number of epicardial the first post-operative year, women were more likely to have been readmitted to hospital than men (44% coronary arteries diseased (Table 2) 
Cardiac drug therapy (Figure 1). Angina had improved highly significantly
Women and men had the same pattern of antiat 3 months and at one year in both men and anginal drug use before CABG surgery (Figure 3 ), women ( p<0.001, sign test). However, angina was with more than 80% taking two or more anti-anginal a greater problem in women than in men. At 12 drugs. Women were more likely to be taking drugs months, 20 women (43%) and 74 men (28%) comused for angina (but also for hypertension) 12 months plained of any angina (OR 2.09; CI 1.10-3.99, after surgery (women 50% vs. men 34%, OR 1.93 p<0.05). Severe angina (grade 3 or 4) was also (95% CI 1.03-3.64, p<0.05). Equal proportions of more common in women than men (23% vs. 11%; women and men were taking double or triple therapy OR 2.35, 95% CI 1.14-4.35, p<0.01) Figure 1 ).
( Figure 3 ). Twelve months after surgery, 86% were After surgery, there were great improvements in taking aspirin, 9% other antithrombotic treatment, self-perceived march tolerance for both women and and only 5% were taking no antithrombotic medicamen ( p<0.001, sign test for pre-operative vs. 3 tion. These drugs were used to the same extent by months, 6 and 12 months) although at 12 months both men and women. the proportion of women able to walk less than 1/4 mile was greater that of men (26% vs. 9%, p<0.01; Other symptoms OR 3.6, 95% CI 1.57-8.28, p<0.005) (Figure 2 ). Similar proportions of women (64%) and men (71%) Twelve months after coronary surgery, fewer women than men were asymptomatic (55% vs. 78%, reported improvement in activity level compared to 
Wound problems
proportions of women and men described their Chest wounds were unhealed in 7% of women vs. most limiting symptom as anginal chest pain (with 3% of men (not significant) 3 months after surgery. or without breathlessness) before surgery (79% Leg wounds were unhealed in 6% of men and 16% of women and 81% of men), with no significant of women (OR 3.19, 95% CI 1.25-8.16). By 12 difference in the proportion of men and women months, chest wounds were healed in all women, who were limited by breathlessness without chest but had not healed in three men. Leg wounds pain.
remained unhealed in two women and three men.
Congestive failure symptoms Neurological sequelae
Congestive failure symptoms (including one or more of ankle swelling, orthopnoea and PND) were less Frontal release reflexes were common after surgery, affecting 29% of women and 40% of men at 3 common 12 months after surgery than before (59% before CABG vs. 25% 12 months after CABG, months, and 22% of women and 20% of men at 12 months. Sensory symptoms around the leg and chest p<0.005, x2). More women than men had congestive symptoms before surgery (women 70% vs. men wounds, including intercostal neuralgia, affected 40% of men and 36% of women 3 months after 34%, p<0.001) and afterwards (at 3 months women 41% vs. men 14%, p<0.005; at 12 months, women CABG surgery, and this figure was unchanged at 12 months (39% of men vs. 40% of women). Sensory 39% vs. men 14%, p<0.001).
or 
Discussion
In this consecutive series of patients followed-up for Symptoms 1 year after elective coronary artery surgery, both Our data show women had more severe angina women and men improved considerably after surbefore coronary surgery than men and, although they gery. This was a high-morbidity population prior to still gained substantially, they continue to experience surgery, with 71% having grade 3 or 4 angina, 50% more angina following surgery. Similar findings have 3-vessel CAD, and 90% taking two or more antibeen reported by others.20,26 Following surgery, anginal drugs. In comparison to men, women were women are also more likely to be readmitted to even more symptomatic prior to surgery, suggesting hospital (Table 3) , have poorer self-reported effort a degree of selection bias. However angiographicallytolerance (Figure 2 ), and to be taking anti-anginal defined CAD severity was comparable in women medication ( Figure 3 ). Women have more nonand men. Overall, women obtained a poorer result ischaemic symptoms, e.g. poorer self-perceived effort from coronary grafting, with a consistent pattern of tolerance, than men before and after surgery, and a higher mortality and morbidity.
greater proportion of women than men are principally restricted by breathlessness rather than chest
Clinical outcome
pain (15% women vs. 8% men before surgery, 35% women vs. 17% men 12 months after surgery). Hospital mortality was 3.4% (3.4% for men and 3.6% for women) and surgical 30-day mortality 4.0% Consistent with this, more women than men in this cohort had symptoms of heart failure before and (3.7% for men and 5.4% for women). These overall figures contrast sharply with those for the CASS after coronary surgery. surgical group (1.4%)1 but are similar to the ECSS surgical group2 and more recent prospective epidemiExplanations for the gender differences ological studies.13 Mortality in cohort studies is also likely to exceed that in randomized studies, because
The outcome after coronary surgery was consistently poorer in women across a wide range of clinical non-consenters in randomized trials have higher morbidity and mortality than consenters. [14] [15] [16] [17] measures and there are a number of possible explanations for this. Patients who did not survive did not have excessive comorbidity and did not undergo a significantly First, women present with coronary artery disease at a later age than men and they may therefore have different operation compared to survivors (data not presented). However, our cohort is an older patient more extensive disease.29 However, in this cohort women were no older, and the duration of illness population with more severe symptoms than the randomized cohort studies.1,2 They are, interestingly, was no different to that in men (Table 1) . They may have more severe disease in that a higher proportion less rather than more likely to smoke. In a recent prospective CABG surgery trial performed in of women than men had severe restrictive angina before surgery and they have a higher prevalence of Denmark,13 a similar perioperative mortality was observed. In addition, recent data18 suggests that the hypertension. This, however, is not reflected in a higher proportion of major epicardial coronary arterperioperative mortality in this study is appropriate to an older more symptomatic patient population. A ies with severe obstructive disease (Table 2) . Second, completeness of revascularization of ischvery recent publication of real clinical practice spanning 18 years demonstrates a surgical risk for aemic myocardium is an important determinant of outcome after surgery30-33 and the extent of revascuwomen and men almost identical in a cohort of a similar age to ours. 19 larisation may differ between men and women. Although men and women in this cohort have a Mortality is higher in women than men from the point of surgery onwards (Figure 1) , with a 12-month similar proportion of major epicardial coronary arteries with significant disease, women received fewer all-cause mortality of 14.3% for women vs. 6.4% for men (OR 2.4, 95% CIs 1.09-6.30, p<0.001, log grafts, particularly to circumflex coronary artery territory (58% of women vs. 79% of men, p<0.05; rank). At least 85% of this mortality was cardiac or Table 2 ). While this may be appropriate for the referral bias, and yet the majority of women in this series had improved symptoms, mobility, and distribution of disease in the native coronary arteries, it raises the possibility that less complete revascureduced need for treatment following surgery. Of those women surviving to 12 months after CABG, larization in women compared with men leads to poorer results from surgery. If true, this may reflect 58% were free of angina, 50% were taking no antianginal drugs, only 15% had angina as their limiting the technical difficulty of surgery to smaller coronary vessels in women compared to men.21,34 In support symptom, and 64% were more active than before surgery. We believe this study highlights the need of this, in our study, women had a smaller body surface area than men (1.76 (SD 0.30) m2 for women for improved risk stratification in the treatment of women with severe angina and a consideration of vs. 1.91 (0.22) m2 in men, p<0.005), and small body surface area was predictive of poorer surgical alternative treatment strategies for those women destined to have a poor outcome from CABG. results in previous studies. 20, 21 Third, it may be that despite adequate revascularization women have accelerated graft closure or accel-
